Guidance for 2026

Terveystalo expects its full-year 2026 adjusted operating profit (EBIT) to be EUR 110–120 million (2025: EUR 156.3 million).

Guidance assumptions

In January–September 2026, profitability was clearly below the level of the corresponding period in 2025, and the demand development was weak. The demand environment is expected to remain challenging in the fourth quarter.

Revenue from outsourcing operations in the Portfolio Businesses segment is expected to decrease by approximately EUR 25 million due to expiring contracts. The guidance includes Hohde Group as of 4 September 2026. These estimates do not include the acquisition of Silmäasema or any other significant acquisitions or divestments.